Biotek-snakken — Juli 2021
-
"ANALYSIS-Biogen Alzheimer's drug slow to take off as U.S. Medicare wrestles with coverage
21/7 12:00
U.S. hospitals that were expected to be early adopters of Biogen’s Alzheimer’s drug have treated only a handful of patients since its early June approval as they wait for the first payments from the government’s Medicare program for people aged 65 and older...."
-
3 Healthcare Stocks That Could Make You Rich https://www.nasdaq.com/articles/3-healthcare-stocks-that-could-make-you-rich-2021-07-21
-
Investeringspodcasten - Sådan investerer Hansen & Larsen selv.
I den første af 3 sommerspecials fortæller Hansen & Larsen om aktier, som har givet gode afkast det seneste år og hvorfor Zealand Pharma, Hansa Biopharma, AMBU og Anavex kan vise sig at blive gode investeringsbekendtskaber. Få uddybningen i afsnit 75. https://www.proinvestor.com/index.php?p=debat_1&postid=95341
-
Orphazyme op 14% - skal vi nu til det circus igen?:)
-
-
Vort nye Nasdaq feed er oppe at køre nu. https://www.proinvestor.com/nasdaq-aktienyheder/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind